Search Results

There are 11965 results for: content related to: Review article: proton pump inhibitors with clopidogrel – evidence for and against a clinically-important interaction

  1. You have free access to this content
    Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment

    Cardiovascular Therapeutics

    Volume 29, Issue 6, December 2011, Pages: e100–e111, Shinichiro Uchiyama

    Version of Record online : 31 JUL 2011, DOI: 10.1111/j.1755-5922.2010.00202.x

  2. You have free access to this content
    The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro

    British Journal of Pharmacology

    Volume 166, Issue 8, August 2012, Pages: 2362–2370, V Ancrenaz, J Desmeules, R James, P Fontana, J-L Reny, P Dayer and Y Daali

    Version of Record online : 24 JUL 2012, DOI: 10.1111/j.1476-5381.2012.01946.x

  3. Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans

    The Journal of Clinical Pharmacology

    Volume 50, Issue 2, February 2010, Pages: 126–142, Dr Nagy A. Farid, Dr Atsushi Kurihara and Dr Steven A. Wrighton

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009343005

  4. You have free access to this content
    Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo

    Journal of Bone and Mineral Research

    Volume 27, Issue 11, November 2012, Pages: 2373–2386, Susanne Syberg, Andrea Brandao-Burch, Jessal J Patel, Mark Hajjawi, Timothy R Arnett, Peter Schwarz, Niklas R Jorgensen and Isabel R Orriss

    Version of Record online : 16 OCT 2012, DOI: 10.1002/jbmr.1690

  5. You have free access to this content
    Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?

    British Journal of Clinical Pharmacology

    Volume 72, Issue 4, October 2011, Pages: 697–706, Terry K. W. Ma, Yat-Yin Lam, Victoria P. Tan and Bryan P. Yan

    Version of Record online : 9 SEP 2011, DOI: 10.1111/j.1365-2125.2011.03949.x

  6. Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 541–552, Mohamed Ali Lassoued, Souad Sfar, Abderrahman Bouraoui and Fathia Khemiss

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01434.x

  7. Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans

    Clinical Pharmacology & Therapeutics

    Volume 97, Issue 6, June 2015, Pages: 650–658, EK Tarkiainen, MT Holmberg, A Tornio, M Neuvonen, PJ Neuvonen, JT Backman and M Niemi

    Version of Record online : 9 MAY 2015, DOI: 10.1002/cpt.101

  8. Personalizing Antiplatelet Therapy With Clopidogrel

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 4, October 2012, Pages: 476–485, D Trenk, O Zolk, M F Fromm, F-J Neumann and W Hochholzer

    Version of Record online : 5 SEP 2012, DOI: 10.1038/clpt.2012.133

  9. You have free access to this content
    Clopidogrel “Resistance”: Where are We Now?

    Cardiovascular Therapeutics

    Volume 31, Issue 1, February 2013, Pages: 3–11, Zeshan Qureshi and Alex R. Hobson

    Version of Record online : 3 AUG 2011, DOI: 10.1111/j.1755-5922.2011.00296.x

  10. Pharmacokinetics of vicagrel, a promising analog of clopidogrel, in rats and beagle dogs

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 2, February 2013, Pages: 741–749, Zhixia Qiu, Ning Li, Xin Wang, Fengjie Tian, Qi Liu, Ling Song, Zhen Fan, Yang Lu and Xijing Chen

    Version of Record online : 28 NOV 2012, DOI: 10.1002/jps.23394

  11. Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 1, January 2011, Pages: 65–74, D J Angiolillo, C M Gibson, S Cheng, C Ollier, O Nicolas, L Bergougnan, L Perrin, F P LaCreta, F Hurbin and M Dubar

    Version of Record online : 15 SEP 2010, DOI: 10.1038/clpt.2010.219

  12. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  13. Influence of CYP2C19 loss-of-function variants on the metabolism of clopidogrel in patients from north-western China

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 3, June 2015, Pages: 308–314, R. Lin, L. Zhang, P. Zhang, L. Zhou, T. Liu, Y. Li, W. Zhang, W. Wang and J. Zhang

    Version of Record online : 24 MAR 2015, DOI: 10.1111/jcpt.12254

  14. You have free access to this content
    Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation

    British Journal of Clinical Pharmacology

    Volume 74, Issue 1, July 2012, Pages: 161–170, Morten Schmidt, Martin B. Johansen, Michael Maeng, Anne Kaltoft, Lisette O. Jensen, Hans-Henrik Tilsted, Hans E. Bøtker, John A. Baron and Henrik Toft Sørensen

    Version of Record online : 11 JUN 2012, DOI: 10.1111/j.1365-2125.2012.04169.x

  15. Differential Impact of Selective Serotonin Reuptake Inhibitors on Platelet Response to Clopidogrel: A Randomized, Double-Blind, Crossover Trial

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 2, February 2015, Pages: 140–147, Bruria Hirsh/Rokach, Galia Spectre, Ela Shai, Amit Lotan, Amit Ritter, Fadiea Al-Aieshy, Rickard E. Malmström, David Varon and Ronny Alcalai

    Version of Record online : 17 FEB 2015, DOI: 10.1002/phar.1542

  16. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  17. Drug Interaction Between Clopidogrel and Proton Pump Inhibitors

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 30, Issue 3, March 2010, Pages: 275–289, Tina J. Liu and Dr. Cynthia A. Jackevicius

    Version of Record online : 5 APR 2012, DOI: 10.1592/phco.30.3.275

  18. Platelet ADP P2Y12 Inhibitors: Thienopyridines

    Therapeutic Advances in Thrombosis, Second Edition

    Joseph D. Foley, David J. Moliterno, Pages: 26–46, 2012

    Published Online : 3 OCT 2012, DOI: 10.1002/9781118410875.ch3

  19. You have free access to this content
    Genetics of platelet inhibitor treatment

    British Journal of Clinical Pharmacology

    Volume 77, Issue 4, April 2014, Pages: 642–653, Dietmar Trenk and Willibald Hochholzer

    Version of Record online : 20 MAR 2014, DOI: 10.1111/bcp.12230

  20. You have free access to this content
    Potentiation of clopidogrel active metabolite formation by rifampicin leads to greater P2Y12 receptor blockade and inhibition of platelet aggregation after clopidogrel

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 8, August 2010, Pages: 1820–1827, H. M. JUDGE, S. B. PATIL, R. J. BUCKLAND, J. A. JAKUBOWSKI and R. F. STOREY

    Version of Record online : 21 MAY 2010, DOI: 10.1111/j.1538-7836.2010.03925.x